Gawecka Agnieszka, Mierzewska-Schmidt Magdalena
Anaesthesiol Intensive Ther. 2014 Apr-Jun;46(2):61-4. doi: 10.5603/AIT.2014.0013.
The need for long preoperative fasting has been questioned. Recent data shows that intake of an oral carbohydrate-containing clear fluid prior to anaesthesia is safe and may have a positive impact on recovery and metabolic status and could improve glucose tolerance. Such solutions are routinely used in adults but not children. The aim of this study was to evaluate the safety, tolerance and influence of oral carbohydrate on selected metabolic parameters in children.
With ethics committee approval and parental informed consent, 20 children, aged 4-17 years, ASA status I or II, scheduled for abdominal or thoracic surgery were randomised either to Group 1 - receiving a 12.6% carbohydrate-containing drink (10 mL kg(-1) the evening before surgery and two hours before anaesthesia), or the control Group 2 - fasting. Serum glucose and insulin concentration were measured four times: before and after anaesthesia, in the evening after surgery, and the following morning. IGF-1 concentration was measured once, before surgery. Insulin resistance was assessed by the HOMA-IR equation.
Oral carbohydrate solution was well tolerated and no adverse events were noted. Glucose concentrations were within the normal range in both groups. Insulin concentration did not show significant differences between groups, however before surgery it tended to be lower in Group 1. Insulin resistance after surgery was significantly higher in Group 2 (2.0 vs. 0.62, P = 0.03), also the increase in insulin resistance after operation was significant only in the control group (P = 0.03).
Oral carbohydrates are safe, well tolerated and do not cause any perioperative adverse events. They seem to improve postoperative metabolism by decreasing insulin resistance.
术前长时间禁食的必要性受到质疑。最近的数据表明,麻醉前摄入含碳水化合物的清亮口服液体是安全的,可能对恢复和代谢状态有积极影响,并可改善糖耐量。此类溶液常用于成人,但未用于儿童。本研究的目的是评估口服碳水化合物对儿童选定代谢参数的安全性、耐受性及影响。
经伦理委员会批准并获得家长知情同意后,将20例年龄4 - 17岁、美国麻醉医师协会(ASA)分级为I或II级、计划行腹部或胸部手术的儿童随机分为两组:第1组在手术前一晚和麻醉前两小时接受12.6%的含碳水化合物饮料(10 mL/kg);对照组(第2组)禁食。分别在麻醉前、麻醉后、术后当晚及次日早晨四次测量血清葡萄糖和胰岛素浓度。术前测量一次胰岛素样生长因子-1(IGF-1)浓度。采用稳态模型评估法(HOMA-IR)评估胰岛素抵抗。
口服碳水化合物溶液耐受性良好,未观察到不良事件。两组血糖浓度均在正常范围内。两组间胰岛素浓度无显著差异,但术前第1组胰岛素浓度有降低趋势。术后第2组胰岛素抵抗显著高于第1组(2.0 vs. 0.62,P = 0.03),且仅对照组术后胰岛素抵抗增加显著(P = 0.03)。
口服碳水化合物安全、耐受性良好,不会引起任何围手术期不良事件。它们似乎通过降低胰岛素抵抗改善术后代谢。